119 related articles for article (PubMed ID: 36123875)
1. Association between small dense LDL levels and hepatic fibrosis in patients with nonalcoholic fatty liver disease.
Young Kim S; Mun S; Yu JH; Jin YJ; Ju Suh Y; Cho SH; Lee JW
Medicine (Baltimore); 2022 Sep; 101(37):e30527. PubMed ID: 36123875
[TBL] [Abstract][Full Text] [Related]
2. Correlation between the small dense LDL level and nonalcoholic fatty liver disease: Possibility of a new biomarker.
Hwang HW; Yu JH; Jin YJ; Suh YJ; Lee JW
Medicine (Baltimore); 2020 Jul; 99(28):e21162. PubMed ID: 32664153
[TBL] [Abstract][Full Text] [Related]
3. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile.
Siddiqui MS; Fuchs M; Idowu MO; Luketic VA; Boyett S; Sargeant C; Stravitz RT; Puri P; Matherly S; Sterling RK; Contos M; Sanyal AJ
Clin Gastroenterol Hepatol; 2015 May; 13(5):1000-8.e3. PubMed ID: 25311381
[TBL] [Abstract][Full Text] [Related]
4. Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations.
Huang H; Xie J; Hou L; Miao M; Xu L; Xu C
J Diabetes Investig; 2024 Apr; 15(4):491-499. PubMed ID: 38108613
[TBL] [Abstract][Full Text] [Related]
5. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
[TBL] [Abstract][Full Text] [Related]
6. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
[TBL] [Abstract][Full Text] [Related]
7. Fibroscan and low-density lipoprotein as determinants of severe liver fibrosis in diabetic patients with nonalcoholic fatty liver disease.
Jaafar RF; Hajj Ali AM; Zaghal AM; Kanso M; Habib SG; Halaoui AF; Daniel F; Mokaddem F; Khalife MJ; Mukherji DM; Faraj WG
Eur J Gastroenterol Hepatol; 2019 Dec; 31(12):1540-1544. PubMed ID: 31135513
[TBL] [Abstract][Full Text] [Related]
8. Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India.
Parikh P; Patel J; Ingle M; Sawant P
Indian J Gastroenterol; 2015 May; 34(3):200-8. PubMed ID: 26108652
[TBL] [Abstract][Full Text] [Related]
9. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
10. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
Kaswala DH; Lai M; Afdhal NH
Dig Dis Sci; 2016 May; 61(5):1356-64. PubMed ID: 27017224
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
[TBL] [Abstract][Full Text] [Related]
12. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
[TBL] [Abstract][Full Text] [Related]
13. LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.
Imajo K; Hyogo H; Yoneda M; Honda Y; Kessoku T; Tomeno W; Ogawa Y; Taguri M; Mawatari H; Nozaki Y; Fujita K; Kirikoshi H; Saito S; Sumida Y; Ono M; Wada K; Nakajima A; Eguchi Y
PLoS One; 2014; 9(12):e115403. PubMed ID: 25541989
[TBL] [Abstract][Full Text] [Related]
14. Serum β-trophin level as a new marker for noninvasive assessment of nonalcoholic fatty liver disease and liver fibrosis.
Cengiz M; Ozenirler S; Kocabiyik M
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):57-63. PubMed ID: 26513612
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.
Staufer K; Halilbasic E; Spindelboeck W; Eilenberg M; Prager G; Stadlbauer V; Posch A; Munda P; Marculescu R; Obermayer-Pietsch B; Stift J; Lackner C; Trauner M; Stauber RE
United European Gastroenterol J; 2019 Oct; 7(8):1113-1123. PubMed ID: 31662868
[TBL] [Abstract][Full Text] [Related]
16. A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease.
Aykut UE; Akyuz U; Yesil A; Eren F; Gerin F; Ergelen R; Celikel CA; Yilmaz Y
Scand J Gastroenterol; 2014 Nov; 49(11):1343-8. PubMed ID: 25259621
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
[TBL] [Abstract][Full Text] [Related]
18. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ
Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007
[TBL] [Abstract][Full Text] [Related]
19. FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran.
Amernia B; Moosavy SH; Banookh F; Zoghi G
BMC Gastroenterol; 2021 Dec; 21(1):453. PubMed ID: 34861841
[TBL] [Abstract][Full Text] [Related]
20. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
